Klor-con and Acetabulum fracture - a phase IV clinical study of FDA data

Summary:

Acetabulum fracture is reported as a side effect among people who take Klor-con (potassium chloride), especially for people who are female, 60+ old, also take Norco, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Acetabulum fracture when taking Klor-con. It is created by eHealthMe based on reports of 27,036 people who have side effects when taking Klor-con from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Acetabulum fracture?

Acetabulum fracture (socket of the hip joint- fracture) is found to be associated with 161 drugs and 171 conditions by eHealthMe. Check the latest studies of Acetabulum fracture.

On Aug, 06, 2026

27,036 people reported to have side effects when taking Klor-con.
Among them, 18 people (0.07%) have Acetabulum fracture.

$Could Klor-con cause Acetabulum fracture?$

Among these 18 people:

What is the gender of people who have Acetabulum fracture when taking Klor-con? *

female: 88.89 %
male: 11.11 %

What is the age of people who have Acetabulum fracture when taking Klor-con? *

What are other drugs people take besides Klor-con? *

What are other side effects people have besides Acetabulum fracture? *

Cardiac Failure Congestive: 18 people, 100.00%
Fall: 18 people, 100.00%
Oedema (fluid collection in tissue): 18 people, 100.00%
Metastases To Bone (cancer spreads to bone): 17 people, 94.44%
Lymphoedema (localized fluid retention and tissue swelling): 17 people, 94.44%
Kidney Stones: 17 people, 94.44%
Vitamin D Decreased: 17 people, 94.44%
Joint Swelling: 17 people, 94.44%
Injury: 17 people, 94.44%
Mumps (a virus that can lead to swelling and pain in the salivary glands, along with fever, loss of appetite, and fatigue): 17 people, 94.44%

What are the existing conditions these people have? *

Metastatic Neoplasm (spreadable cancer tumour): 17 people, 94.44%
Breast Cancer Metastatic: 17 people, 94.44%
Hypersensitivity: 12 people, 66.67%
Diabetes: 12 people, 66.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.56%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%
Metastases To Bone (cancer spreads to bone): 1 person, 5.56%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.56%
Cardiac Failure Congestive: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and have Acetabulum fracture?

- Check whether Acetabulum fracture is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Klor-con:

Klor-con (27,547 reports)

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acetabulum fracture:

Acetabulum fracture (161 drugs)

Browse all the conditions that are associated with Acetabulum fracture:

Acetabulum fracture (171 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con) and Klor-con (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.